Compounding this plateau, placebo-controlled cardiovascular outcome trials (CVOTs) are increasingly deemed unethical in patients with established CVD, as current standards of care now include agents with proven cardiovascular efficacy, namely GLP-1RA and SGLT-2 inhibitors
He shares good news over the phone: In the future well have molecules that are three times more effective than the ones we have now. Morales mentions Wegovy, a higher-dose version, which is designed specifically for people who are overweight or obese
I also procured both Mounjaro and its rival Wegovy through two major e-pharmacies, Tata 1mg and Apollo Pharmacy, without undergoing a doctors consultation or the pre-treatment tests that experts strongly recommend before initiating such therapies
Readers - what are your thoughts on GLP-1 receptor agonists for Alzheimers disease
When does sermorelin kick in
What are the best peptides for arthritis